Legislation and news

Marijuana: a dangerous, addictive drug or relief for pain patients?

Originally published on Inflexxion Marijuana was valued for its healing powers in many ancient cultures. In ancient Greece, cannabis cured inflammation. In India, it was offered as a cure for leprosy. In China, it was used for just about everything. By 1850, marijuana was listed in the United States Pharmacopeia and was considered acceptable for use in… Read more »

The Opioid Crisis: A Global Problem

It’s not difficult to imagine the opioid crisis as an isolated problem that only exists within the United States. Drug overdose is the leading cause of death for Americans under 50, now leading firearm and motor vehicle deaths, cutting short 91 lives each day. President Trump recently labeled the opioid epidemic a “public health emergency.”… Read more »

Opioid REMS Update 2013

When we last covered the topic of the FDA’s intended plans for curbing opioid risk, we felt confident that one thing was for sure – education would likely be a key ingredient of the ultimate implemented solution. As it turns out, our assumption was correct. As we mentioned in our opioid REMS update 2012, on Tuesday, April… Read more »

New Approaches to Combating Abuse of Opioids

Opioids play an important and omnipresent role in the treatment of moderate to severe acute and chronic pain. The fact of the matter is that in patients with acute pain, such as postoperative pain, opioids are utilized as the first-line treatment at least 98% of the time. Opioids are also recognized as the cornerstone of… Read more »

FDA Announces New Safety Measures for Extended-Release and Long-Acting Opioids

On September 10, 2013, the Food and Drug Administration (FDA) announced a number of changes that are intended to increase the safety of extended-release and long-acting (ER/LA) opioid medications. This announcement applies to all currently marketed ER/LA opioids, and implements two specific approaches to achieve the goal of combatting “the crisis of misuse, abuse, addiction, overdose, and death” according… Read more »

Opioid REMS Becomes a Reality

When PainEDU.org last covered the topic of the Food and Drug Administration (FDA’s) intended plans for curbing opioid risk, we felt confident one thing was for sure – that education would likely be a key ingredient in the ultimate implemented solution. On Tuesday, April 19th, 2011, a press conference was held to announce the White House’s National Prescription… Read more »